Science Explorer Interactive view Map
Funder · Basel · ??

Novartis Institutes for BioMedical Research

In research, Novartis Institutes for BioMedical Research stands highest in Life Sciences (#1,475 of 14,347 worldwide), Medicine (#3,187 of 17,978 worldwide) and Biochemistry, Genetics and Molecular Biology (#1,550 of 7,814 worldwide), over all time.

novartis.comROR OpenAlex
World rank, 2022–2025
#8,423
of 28,054 · #3,351 all time
Rank in ??
#135
of 692
Research works
1.1k
▼ 23% vs 2013–17
Citations
78k
68.3 per fractional work
Top-10% rate
33.7%
record average 16.5%
Open access
48%
world 28%

What is Novartis Institutes for BioMedical Research known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #1,475 of 14,347 33.1%548
MedicineField #3,187 of 17,978 31.4%391
Biochemistry, Genetics and Molecular BiologyField #1,550 of 7,814 33.7%381
Molecular BiologySubfield #991 of 4,961 34.3%292
Health SciencesDomain #4,337 of 20,462 31.3%401
Physical SciencesDomain #7,348 of 21,541 35.4%180

Each strip is that field’s whole ranked pool, with the notch where Novartis Institutes for BioMedical Research sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.39× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.18× its world share, 27 worksBiochemistry, Geneti…Immunology and Microbiology: 7.48× its world share, 7 worksImmunology and Micro…Neuroscience: 1.54× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.72× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 0.65× its world share, 0 worksChemical EngineeringChemistry: 3.28× its world share, 5 worksChemistryComputer Science: 0.49× its world share, 4 worksComputer ScienceEngineering: 0.16× its world share, 2 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.52× its world share, 2 worksMaterials ScienceMathematics: 0.46× its world share, 0 worksMathematicsPhysics and Astronomy: 0.01× its world share, 0 worksPhysics and AstronomyDentistry: 0.16× its world share, 0 worksDentistryHealth Professions: 0.15× its world share, 0 worksHealth ProfessionsMedicine: 2.13× its world share, 40 worksMedicineVeterinary: 3.64× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.09× its world share, 0 worksBusiness, Management…Decision Sciences: 0.60× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.18× its world share, 0 worksEconomics, Econometr…Psychology: 0.19× its world share, 1 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.5×. Every wedge is a field page.

Which keywords describe research at Novartis Institutes for BioMedical Research?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Medicinal Chemistry, Pharmacokinetics, Inflammation, Regulation, Monoclonal Antibodies, Molecular Docking and Mutation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer8▲ 5.8×30 topics
  2. Epidemiology6▲ 1.54×39 topics
  3. Inflammation6▲ 2.9×42 topics
  4. Machine Learning5▲ 1.61×8 topics
  5. Medicinal Chemistry5▲ 18×8 topics
  6. Pharmacokinetics5▲ 18×2 topics
  7. Regulation4▲ 7.3×6 topics
  8. Monoclonal Antibodies4▲ 42×3 topics
  9. Cancer Therapy4▲ 6.5×11 topics
  10. Molecular Docking4▲ 29×2 topics
  11. Mutation4▲ 19×5 topics
  12. Drug Target Identification3▲ 37×1 topic
  13. Glycosylation3▲ 31×3 topics
  14. Virtual Screening3▲ 37×1 topic
  15. Drug Discovery3▲ 14×6 topics
  16. Therapeutic Targets3▲ 21×5 topics
  17. Therapeutic Antibodies3▲ 43×2 topics
  18. Prognostic Factors3▲ 6.5×9 topics
  19. Antibody Engineering3▲ 50×1 topic
  20. Fc Receptors3▲ 50×1 topic
  21. Stem Cells3▲ 11×7 topics
  22. Transcriptional Regulation3▲ 16×7 topics
  23. Cell Proliferation2▲ 29×3 topics
  24. Innate Immunity2▲ 7.8×6 topics
  25. Genetics2▲ 3.4×7 topics
  26. Angiogenesis2▲ 6.8×11 topics
  27. Rituximab2▲ 14×3 topics
  28. BCR-ABL2▲ 77×1 topic
  29. Imatinib2▲ 77×1 topic
  30. Mechanotransduction2▲ 30×4 topics
  31. Tumor Microenvironment2▲ 4.5×8 topics
  32. Chronic Lymphocytic Leukemia2▲ 43×1 topic
  33. Genomic Aberrations2▲ 43×1 topic
  34. Cell Signaling2▲ 12×6 topics
  35. Molecular Dynamics2▲ 11×2 topics
  36. PET Imaging2▲ 11×4 topics
  37. Cancer Immunotherapy2▲ 11×2 topics
  38. Genetic Variation2▲ 7.9×4 topics
  39. Hippo Pathway2▲ 125×1 topic
  40. YAP/TAZ2▲ 125×1 topic

Which research topics does Novartis Institutes for BioMedical Research publish most on?

By volume in 2022–2025: Computational Drug Discovery Methods, Monoclonal and Polyclonal Antibodies Research, Chronic Myeloid Leukemia Treatments and Chronic Lymphocytic Leukemia Research.

Computational Drug Discovery Methods: 3 fractional worksMonoclonal and Polyclonal Antibodies Research: 3 fractional worksChronic Myeloid Leukemia…2Chronic Myeloid Leukemia Treatments: 2 fractional worksChronic Lymphocytic Leuk…2Chronic Lymphocytic Leukemia Research: 2 fractional worksHippo pathway signaling and YAP/TAZ: 2 fractional worksPharmacogenetics and Drug Metabolism: 1 fractional worksMachine Learning in Mate…1Machine Learning in Materials Science: 1 fractional worksProtein Degradation and Inhibitors: 1 fractional worksChemical Synthesis and Analysis: 1 fractional worksCAR-T cell therapy research: 1 fractional works
Computational Theory and MathematicsRadiology, Nuclear Medicine and ImagingHematologyGenetics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Computational Drug Discovery Methods Computational Theory and Mathematics 3 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  3. 3 Chronic Myeloid Leukemia Treatments Hematology 2 works
  4. 4 Chronic Lymphocytic Leukemia Research Genetics 2 works
  5. 5 Hippo pathway signaling and YAP/TAZ Cell Biology 2 works
  6. 6 Pharmacogenetics and Drug Metabolism Pharmacology 1 works
  7. 7 Machine Learning in Materials Science Materials Chemistry 1 works
  8. 8 Protein Degradation and Inhibitors Molecular Biology 1 works
  9. 9 Chemical Synthesis and Analysis Molecular Biology 1 works
  10. 10 CAR-T cell therapy research Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.6%not open52.4%

World: 28% of research is openly available.

with international co-authors52.1%domestic only47.9%

World: 19% is written across borders.

How has Novartis Institutes for BioMedical Research's research output changed?

Output in 2018–2022 was 23% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Basel

All research institutions in Basel

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.